Maze Therapeutics Inc. (MAZE)
NASDAQ: MAZE
· Real-Time Price · USD
12.93
-0.38 (-2.85%)
At close: Jun 17, 2025, 2:21 PM
-2.85% (1D)
| Bid | 12.82 |
| Market Cap | 566.08M |
| Revenue (ttm) | 2.5M |
| Net Income (ttm) | -80.91M |
| EPS (ttm) | 0.07 |
| PE Ratio (ttm) | 184.64 |
| Forward PE | -3.89 |
| Analyst | Buy |
| Ask | 13.57 |
| Volume | 32,399 |
| Avg. Volume (20D) | 212,282 |
| Open | 13.65 |
| Previous Close | 13.31 |
| Day's Range | 12.92 - 13.65 |
| 52-Week Range | 6.71 - 17.00 |
| Beta | 1.85 |
About MAZE
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol MAZE
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for MAZE stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 months ago
-10.08%
Maze Therapeutics shares are trading lower on poss...
Unlock content with
Pro Subscription
3 months ago
-2.31%
Maze Therapeutics shares are trading higher after JP Morgan initiated coverage on the stock with an Overweight rating and announced a price target of $30. Additionally, Leerink Partners initiated coverage on the stock with an Outperform rating and announced a price target of $28.
4 months ago · seekingalpha.com
U.S. IPO Weekly Recap: Active January Closes Out With Several Sizable IPOsFive IPOs listed this week, all of which raised over $100 million; one direct listing and three SPACs also debuted. Four microcaps submitted initial filings this week - Vistek, Awaysis Capital, QMSK T...